Open research questions in Pain Mechanisms and Treatments
926 gap statements mined from Pain Mechanisms and Treatments papers in our 7.9M-paper local library, which holds 3,841 papers on the topic — drawn mostly from each paper's own stated research gap, future-work, challenge and limitation notes, and its abstract. The ones listed below are a selection still marked open; each names the study that raised it, with a DOI link where the paper has one.
Choosing where to publish on Pain Mechanisms and Treatments? See the ranked Medicine journals.
What the literature leaves open
Perineural invasion represents a significant diagnostic and therapeutic challenge due to the lack of standardised methods for detecting this process, as well as its numerous complications and its detrimental impact on patients’ quality of life.
For example, whether the combination of CX3CR1 antagonists or CatS inhibitors with SNM exerts a synergistic analgesic effect remains to be further investigated. 001 complex network, and the role of astrocytes and other glial cells in chronic pain is equally important, which needs to be explored in subsequent studies.
Sacral Nerve Modulation Alleviates Neuropathic Pelvic Pain Through Modulation of the Spinal Immune Microenvironment and Microglial Activation · 2026 · DOIAlterations in amino acid metabolites (e.g., arginine, tyrosine, and gluta‑ mate) have been associated with nerve conduction velocity, but further validation is required before these markers can be translated into clinical use.
Bioenergetic failure in diabetic peripheral neuropathy: from glucotoxicity to multidimensional metabolic imbalance · 2026 · DOIThe mechanisms underlying thalamic neuronal dysfunction in painless DPN remain unclear, but may reflect loss of afferent input to the thalamus, causing a dying back of central nervous system neurons.
Thalamic neuronal and bioenergetic function in painful diabetic peripheral neuropathy: a dual magnetic resonance spectroscopy study · 2026 · DOITreatment protocols employing NSAIDs can result in gastric, hepatic, and renal damage, which is associated with renal damage and constitutes a significant limitation to their clinical application.
Protectin DX reduces inflammatory pain initiated by superoxide anion in mice: targeting leukocyte recruitment, oxidative stress, cytokine production and TRPV1+ nociceptive sensory neuron activation · 2026 · DOIWhile current evidence demonstrates that OMT can shift immune-cell proportions and cytokine patterns, the link to specific transcriptomic changes remains unclear.
A mechanistic hypothesis: osteopathic manipulative therapy may modulate immune cell function in chronic low back pain · 2026 · DOIAlthough pharmacological and genetic studies strongly support a role for Nts signaling in pain modulation, conflicting findings across experimental models underscore the complexity of this system and suggest that NtsR1- and NtsR2-mediated signaling exert distinct, context- and circuit-dependent effects.
Targeting pain where it CouNts: the role of neurotensin signaling in pain and analgesia · 2026 · DOISecond, molecular analyses were limited to the L3–L5 spinal cord; the injured sciatic nerve and dorsal root ganglia were not examined, and the sampled spinal region does not encompass the full L4-S3 distribution associated with sciatic input.
Boldine Attenuates Mechanical Allodynia and Mitigates Transcriptomic Changes in a Mouse Model of Chronic Constriction Injury · 2026 · DOIFourth, the 250-day observation period is one of the longest in neuropathic pain research, yet whether ACI-induced persistent pain can endure beyond this timeframe remains unclear.
Transient peripheral compression induces persistent central pain: the acute constriction injury model · 2026 · DOIDelta-9-tetrahydrocannabinol (THC) has shown analgesic and hypnotic effects in preclinical and clinical studies, but the mechanisms underlying these actions—and the consistency of efficacy across NP models—remain incompletely understood.
300. Delta-9-tetrahydrocannabinol (THC) alleviates neuropathic pain and insomnia through activation of the reticular thalamus · 2026 · DOIBackground/Aim: Temporomandibular disorders (TMD) are frequently accompanied by persistent pain, but the underlying mechanisms remain incompletely understood.
Macrophage-derived Exosomes Regulate Neuronal ACSL6 in Experimental Temporomandibular Disorder Pain · 2026 · DOIIn addition to the neuronal release of BDNF, accumulating evidence suggests a critical role of BDNF from the neuroimmune system as a pain mechanism, but despite that, the picture remains unclear. Spinal BDNF promotes facilitation, but the cellular source of BDNF remains unclear.
Future research should focus on elucidating the role of TNF-α signaling (by TNFR1 and TNFR2) that induces physiologically different and typically antagonistic effects.
Despite substantial advances in understanding the interplay between oxidative stress, inflammation, mitochondrial dysfunction, and cellular senescence in neuropathic pain, several critical knowledge gaps remain. First, the precise temporal dynamics and tissue specificity of these processes are incompletely mapped, limiting the ability to identify optimal therapeutic windows.
Oxidative Stress, Inflammation, and Cellular Senescence in Neuropathic Pain: Mechanistic Crosstalk · 2025 · DOI1653346 including CeA-CRF neurons, contribute to lasting mechanical hypersensitivity following early-life pain and stress, their failure to completely reverse/block the development of stress-induced hypersensitivity suggests other neuronal populations within the amygdala may also play a role, but the specific populations of neurons responsible remain unclear.
Early-life pain alters excitability of corticotropin-releasing factor-expressing neurons in the central amygdala and stress-induced hypersensitivity during adolescence · 2025 · DOIFuture research should prioritize rigorous clinical trials to establish the safety, dosage parameters, and therapeutic potential of capsaicin and RTX in diverse neuropathic pain conditions, including diabetic neuropathy, post-surgical pain, and trauma-induced neuropathy.
A novel approach to completely alleviate peripheral neuropathic pain in human patients: insights from preclinical data · 2025 · DOIHowever, the alterations in sleep architecture under NP conditions and the mechanisms underlying both pain and sleep disturbances remain poorly understood.
Neuropathic pain impairs sleep architecture, non-rapid eye movement sleep, and reticular thalamic neuronal activity · 2025 · DOIThe reticular thalamic nucleus (RTN) plays a crucial role in non-rapid eye movement sleep (NREMS) and pain processing, but its involvement in NP-related sleep disruptions has not been fully elucidated.
Neuropathic pain impairs sleep architecture, non-rapid eye movement sleep, and reticular thalamic neuronal activity · 2025 · DOIThe need to prevent the nitration of mitochondrial proteins and the loss of their enzymatic activity.
Exploring the Role of Bergamot Polyphenols in Alleviating Morphine-Induced Hyperalgesia and Tolerance through Modulation of Mitochondrial SIRT3 · 2024 · DOIThe lack of understanding of the role of SIRT3 in morphine-induced hyperalgesia and tolerance. The need for alternative treatments for chronic pain that do not lead to tolerance and hyperalgesia.
Exploring the Role of Bergamot Polyphenols in Alleviating Morphine-Induced Hyperalgesia and Tolerance through Modulation of Mitochondrial SIRT3 · 2024 · DOIAnother the is Validation, Writing – review & editing. ST: Formal analysis, Validation, Writing – review & editing. AT: Data curation, Formal analysis, Validation, Writing – review & editing.
New insight into RNA biomarkers in neuropathic pain: a clinician–neuroscientist roadmap to translational testing and treatment monitoring a clinical review · 2026 · DOIThe Patch-seq analyses were a large effort, but are nevertheless limited by their sample size (with 9 of 16 pig neuron populations having four or less neurons) and by the sequencing sensitivity for low-abundance transcripts.
In humans, the GABRA5 gene is associated with learning, psychiatric, and neurological diseases, whereas no reports exist on its association with pain.
208. GABRA5 rs35399885 single nucleotide polymorphism is significantly associated with sensory hypoesthesia and pain sensitivity · 2026 · DOIAnother recommendation published in 2020 stated that the evidence was inconclusive concerning the efficacy of nerve blocks and intrathecal injections for neuropathic pain.
The detection of elevated VPT in patients with T2DM without self-reported neuropathic symptoms supports further investigation of quantitative vibration perception assessment as a potential tool for the early detection of peripheral sensory dysfunction.
Early Sensory Dysfunction in Type 2 Diabetes: Vibration Perception Abnormalities in Patients Without Neuropathic Symptoms · 2026 · DOI
Most-cited papers in Pain Mechanisms and Treatments
- Pain Mechanisms: A New Theory · Science · 1965 · 8,981 citations
- The inflammatory reflex · Nature · 2002 · 3,183 citations
- Empathy for Pain Involves the Affective but not Sensory Components of Pain · Science · 2004 · 3,030 citations
- Impaired Nociception and Pain Sensation in Mice Lacking the Capsaicin Receptor · Science · 2000 · 3,029 citations
- Neuronal Plasticity: Increasing the Gain in Pain · Science · 2000 · 2,991 citations
- The biopsychosocial approach to chronic pain: Scientific advances and future directions. · Psychological Bulletin · 2007 · 2,708 citations
- Pain Affect Encoded in Human Anterior Cingulate But Not Somatosensory Cortex · Science · 1997 · 2,114 citations
- Molecular mechanisms of nociception · Nature · 2001 · 2,077 citations
- Neuropathic pain: aetiology, symptoms, mechanisms, and management · The Lancet · 1999 · 1,706 citations
- Gabapentin for the Symptomatic Treatment of Painful Neuropathy in Patients With Diabetes Mellitus<SUBTITLE>A Randomized Controlled Trial</SUBTITLE> · JAMA · 1998 · 1,220 citations
Most recent work
- Molecular architecture of human dermal sleeping nociceptors · Cell · 2026
- Suzetrigine (VX-548) exhibits activity-dependent effects on human dorsal root ganglion neurons with differential pain etiology · Pain · 2026
- Integrative Proteomics Reveal Neuroimmune and Dopaminergic Alterations Across the Nociceptive Neuraxis in Neuropathic Pain · Cells · 2026
- Monocyte-derived IL-10 drives sex differences in pain duration · Science Immunology · 2026
- Cycloastragenol Alleviates Bone Cancer Pain by Targeting Sirt1 to Inhibit Neuronal Ferroptosis and Promote M2 Microglial Polarization in the Spinal Dorsal Horn of Rats · Phytotherapy Research · 2026
- Unraveling Chronic Pain: From Mechanisms and Risks to Diagnosis and Treatment · MedComm · 2026
- Mixed Pain: Toward a Consensus Definition and a Mechanism‐Based Framework · European Journal of Pain · 2026
- Gastrodin Ameliorates Pain-Depression Comorbidity through SIRT3-Dependent Alleviation of Oxidative Stress and Promotion of Mitochondrial Biogenesis · Molecular Neurobiology · 2026
- IL-6 blockade at the fracture site accelerates bone healing via inflammatory modulation of sensory nerve CGRP signaling · International Immunopharmacology · 2026
- A Biomass-Inspired Hydrogel Patch for Intelligent Pain Monitoring and On-Demand Analgesia · Research · 2026
Find a gap in your own Pain Mechanisms and Treatments sub-topic
This page shows what the Pain Mechanisms and Treatments literature already flags as unresolved. To narrow it to your specific question, search the Research Gap Finder: the search is free with a free account and lists the papers closest to your topic first. Unlocking that topic (50 credits, charged once) fills the comparison table from our 7.9M-paper local library and writes the gaps from its rows.
Open the Research Gap Finder →